USA Flag An official website of the United States government
Official websites use .mil
A .mil website belongs to an official U.S. Department of War organization.
Secure .mil websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .mil website. Share sensitive information only on official, secure websites.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Funding Summary

CDMRP has managed Congressional appropriations totaling $20.3 Billion in the following areas and fiscal years through FY25.

Programs Managed by CDMRP FY Appropriation ($M)
Alcohol and Substance Use Disorders 2014-19, 21-24 $40.0
Amyotrophic Lateral Sclerosis 2007, 09-25 $309.4
Arthritis 2024 $10.0
Autism 2007-24 $164.4
Bone Marrow Failure 2008-24 $71.6
Breast Cancer - Total 1992-25 $4,550.3
Breast Cancer
Breast Cancer Research Semipostal
1992-25
1999-24
$4,521.3
$29
Chronic Myelogenous Leukemia 2002-06 $22.1
Chronic Pain Management 2019-23 $70.0
Combat Readiness-Medical 2019-24 $55.0
Defense Women's Health 1995 $40.0
Deployment Related Medical 2008 $101.9
DOD/VA 1999-00 $6.8
Duchenne Muscular Dystrophy 2011-25 $92.1
Epilepsy 2015-24 $97.5
Genetic Studies of Food Allergies 2009-10 $4.4
Glioblastoma 2024 $10.0
Gulf War Illness 2006, 08-21 $236.0
Hearing Restoration 2017-24 $70.0
Institutionally Based Programs 1995-10 $486.3
Joint Warfighter Medical 2013-24 $519.0
Kidney Cancer 2017-24 $285.0
Lung Cancer 2009-24 $245.5
Lupus 2017-24 $65.0
Melanoma 2019-25 $220.0
Military Burn 2014-25 $108.0
Multiple Sclerosis 2009-24 $153.1
Myeloproliferative Disorders 2004 $4.3
National Prion 2002 $42.5
Neurofibromatosis 1996-24 $452.9
Neurotoxin Exposure Treatment Parkinson's 2014-21 $128.0
Orthotics and Prosthetics Outcomes 2014-23 $125.0
Osteoporosis 1995 $5.0
Ovarian Cancer 1997-25 $556.5
Pancreatic Cancer 2020-24 $66.0
Parkinson's 2022-24 $48.0
Alzheimer's 2014-25 $174.0
Peer Reviewed Cancer 2009-25 $1,174.8
Peer Reviewed Medical 1999-06, 08-25 $4,340.7
Peer Reviewed Orthopaedic 2009-24 $548.5
Prostate Cancer 1997-25 $2,445.0
Rare Cancers 2020-25 $95.0
Reconstructive Transplant 2015-24 $123.0
Scleroderma 2020-21 $10.0
Spinal Cord Injury 2009-24 $477.9
Tick-Borne Disease 2016-24 $55.0
Toxic Exposures 2022-25 $105.0
Traumatic Brain Injury/Psychological Health1 2007, 21-24 $1,001.0
Tuberous Sclerosis Complex 2002-06, 08-24 $121.0
Vision 2013-24 $188.9
TOTALS >>>   $20,321.3
     
(1) Years CDMRP was assigned management of these funds

Application Summary

CDMRP has reviewed over 159,433 research proposals and funded 22,456 awards providing over $19.7 Billion in research funding to organizations throughout the world as a result of appropriations through FY24. Below is a summary of those efforts by program.

Programs Managed by CDMRP Fiscal Year Appropriations Received (in millions) Applications Received Applications Funded (1)
Alcohol and Substance Use Disorders(1) 2014-2019, 2021-2024 $40.0 29 8
Amyotrophic Lateral Sclerosis 2007, 2009-2024 $269.4 1,110 249
Arthritis 2024 $10 130 12
Autism 2007-2024 $164.4 1,982 237
Bone Marrow Failure 2008-2024 $71.6 709 118
Breast Cancer 1992-2024 $4,391.3 65,195 7,378
Breast Cancer Research Semipostal(2) 1999-2024 $28.8 0 81
Chronic Myelogenous Leukemia 2002-2007 $22.1 252 61
Chronic Pain Management 2019-2023 $70.0 419 65
Combat Readiness Medical Research 2019-2024 $55.0 465 30
Defense Women's Health 1995 $40.0 559 69
Deployment Related Medical 2008 $101.9 1,094 58
DoD/VA 1999-2000 $6.8 88 9
Duchenne Muscular Dystrophy 2011-2024 $79.6 496 97
Epilepsy 2015-2024 $97.5 462 103
Genetic Studies of Food Allergies 2009-2010 $4.4 60 9
Glioblastoma 2024 $10.0 452 18
Gulf War Illness 2006, 2008-2021 $236.0 744 239
Hearing Restoration 2017-2024 $70.0 290 68
Institutionally Based Programs(1) 1995-2010 $486.3 306 501
Joint Warfighter Medical(1) 2013-2024 $519.0 520 100
Kidney Cancer 2017-2024 $285.0 1,818 347
Lung Cancer 2009-2024 $245.5 5,364 460
Lupus 2017-2024 $65.0 632 100
Melanoma 2019-2024 $180.0 1,318 212
Military Burn(1) 2014-2024 $98.0 374 80
Multiple Sclerosis 2009-2024 $153.1 1,416 239
Myeloproliferative Disorders Research 2004 $4.3 18 9
National Prion Research Project 2002 $42.5 136 38
Neurofibromatosis 1996-2024 $452.9 2,163 548
Neurotoxin Exposure Treatment Parkinson's (1) 2014-2021 $128.0 689 158
Orthotics and Prosthetics Outcomes 2014-2023 $125.0 446 100
Osteoporosis 1995 $5.0 105 5
Ovarian Cancer 1997-2024 $541.5 5,415 729
Pancreatic Cancer 2020-2024 $66.0 497 102
Parkinson's 2022-2024 $48.0 400 46
Alzheimer's(1) 2014-2024 $159.0 1,058 195
Peer Reviewed Cancer 2009-2024 $1,044.8 8,062 1,180
Peer Reviewed Medical 1999-2006, 2008-2024 $4,190.7 21,297 2,452
Peer Reviewed Orthopaedic 2009-2024 $548.5 1,906 387
Prostate Cancer 1997-2024 $2,370.0 22,090 3,948
Rare Cancers 2020-2024 $77.5 1,484 162
Reconstructive Transplant 2015-2024 $123.0 946 184
Scleroderma 2020-2021 $10.0 91 21
Spinal Cord Injury 2009-2024 $477.9 2,072 380
Tick-Borne Disease 2016-2024 $55.0 398 62
Toxic Exposures 2022-2024 $90.0 736 82
Traumatic Brain Injury/Psychological Health 2007, 2021-2024 $1,001.0 1,254 297
Tuberous Sclerosis 2002-2006, 2008-2024 $121.0.0 1,040 228
Vision 2013-2024 $188.9 846 172
Miscellaneous 23
Total $19,671.2 159,433 22,456

(1)Includes awards transitioned to CDMRP with the merger.

(2)Breast Cancer Research Semipostal funds applications received and reviewed by the Breast Cancer Research Program. BCRS contributed to 81 awards; 45 fully funded and 36 partially funded.

Last updated Wednesday, November 5, 2025